THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 117 filers reported holding THERAVANCE INC in Q4 2014. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $19,056,000 | +27.7% | 1,807,987 | -13.0% | 0.01% | +25.0% |
| Q3 2015 | $14,927,000 | -68.0% | 2,078,976 | -19.5% | 0.00% | -73.3% |
| Q2 2015 | $46,693,000 | +45.2% | 2,584,000 | +26.3% | 0.02% | +36.4% |
| Q1 2015 | $32,160,000 | +16.9% | 2,045,788 | +5.2% | 0.01% | +10.0% |
| Q4 2014 | $27,509,000 | -8.3% | 1,944,121 | +10.8% | 0.01% | 0.0% |
| Q3 2014 | $29,986,000 | -57.0% | 1,754,550 | -25.1% | 0.01% | -54.5% |
| Q2 2014 | $69,792,000 | +31.2% | 2,343,568 | +36.3% | 0.02% | +10.0% |
| Q1 2014 | $53,202,000 | +0.5% | 1,719,516 | +15.8% | 0.02% | +5.3% |
| Q4 2013 | $52,927,000 | +31.5% | 1,484,643 | +50.8% | 0.02% | +18.8% |
| Q3 2013 | $40,234,000 | -2.0% | 984,452 | -7.6% | 0.02% | -11.1% |
| Q2 2013 | $41,040,000 | – | 1,065,138 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 20,395,056 | $607,365,000 | 9.89% |
| Realm Partners LLC | 301,521 | $8,979,000 | 3.75% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,805,837 | $83,558,000 | 2.52% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,447,743 | $221,794,000 | 2.27% |
| SECTORAL ASSET MANAGEMENT INC | 1,743,188 | $51,912,000 | 2.20% |
| Foundation Asset Management, LP | 255,790 | $7,617,000 | 2.19% |
| Proxima Capital Management, LLC | 550,000 | $16,379,000 | 1.93% |
| Roundview Capital LLC | 140,645 | $4,188,000 | 1.69% |
| BB BIOTECH AG | 933,244 | $27,792,000 | 1.32% |
| PERRY CAPITAL | 1,517,208 | $45,182,000 | 1.25% |